Literature DB >> 871282

Efficient oxygen mask for patients undergoing hyperbaric oxygen therapy.

P J Sheffield, R L Stork, T R Morgan.   

Abstract

Hyperbaric oxygen (HBO) is established therapy for various disorders, but its effectiveness depends on the efficiency of the oxygen delivery system. A mask oxygen delivery system, consisting of the standard USAF aviator's A-14 regulator and the MBU-5/P oxygen mask, is installed in all USAF hyperbaric chambers. The efficiency of the mask oxygen delivery system at the USAF Hyperbaric Center, Brooks AFB, Tx, was evaluated breath-by-breath at sea level and 2.4 ATA via two different measuring techniques. Three groups of subjects were evaluated. Four subjects in Group I and seven subjects in Group II were randomly selected to use a single instrumented mask which was improperly fitted. The result was variable inspired oxygen levels from 64% to 100%. Six subjects in Group III wore properly fitted masks and achieved end-inspired oxygen levels ranging from 96% to 99%, for a mean of 97.8 +/- 0.5 (S.E.)%. A mean end-inspired oxygen level of 88,5 +/- 3,5 (S.E.)% was achieved within 5 min of mask donning. Inspiratory gas analyses indicate that the USAF aviator MBU-5/P mask and the A-14 regulator as used at the USAF Hyperbaric Center constitute a highly efficient oxygen delivery system for HBO therapy. This view has been refleced in arterial blood gas measurements and in preliminary data from tissue oxygen measurements in a gas gangrene patient. Future improvements in patient therapy masks are recommended.

Entities:  

Mesh:

Year:  1977        PMID: 871282

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  4 in total

1.  The myopic shift associated with hyperbaric oxygen administration is reduced when using a mask delivery system compared to a hood - a randomised controlled trial.

Authors:  Michael H Bennett; Cheng Fb Hui; Hooi G See; Kwan L Au-Yeung; Christopher Tan; Stephanie Watson
Journal:  Diving Hyperb Med       Date:  2019-12-20       Impact factor: 0.887

Review 2.  Hyperbaric oxygen for patients with multiple sclerosis.

Authors:  J Mertin; W I McDonald
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-31

Review 3.  Monoplace chamber treatment of decompression illness: Review and commentary.

Authors:  Richard Clarke
Journal:  Diving Hyperb Med       Date:  2020-09-30       Impact factor: 0.887

Review 4.  The O2-sensitive brain stem, hyperoxic hyperventilation, and CNS oxygen toxicity.

Authors:  Jay B Dean; Nicole M Stavitzski
Journal:  Front Physiol       Date:  2022-07-26       Impact factor: 4.755

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.